AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
Log in
NASDAQ:FREQ

Frequency Therapeutics Insider Trades

$21.92
-0.55 (-2.45 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$21.11
Now: $21.92▼
$22.24
50-Day Range
$17.76
MA: $21.16▼
$24.96
52-Week Range
$13.60
Now: $21.92▼
$28.78
Volume115,109 shs
Average Volume177,254 shs
Market Capitalization$737.52 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

Frequency Therapeutics (NASDAQ:FREQ) Insider Buying and Selling Activity

Insider Ownership Percentage: 15.40%
Insider Buying (Last 12 Months): $999,990.00
Insider Selling (Last 12 Months): $3,526,293.38

Insider Buying and Selling by Quarter


Frequency Therapeutics (NASDAQ FREQ) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/13/2020Christopher R LooseInsiderSell8,000$22.00$176,000.0087,782  
10/8/2020Christopher R LooseInsiderSell24,000$20.19$484,560.00111,782  
10/5/2020Christopher R LooseInsiderSell8,000$18.35$146,800.00135,782  
10/1/2020Christopher R LooseInsiderSell8,000$18.84$150,720.00135,782  
9/23/2020Christopher R LooseInsiderSell4,500$21.13$95,085.00146,412  
9/9/2020Christopher R LooseInsiderSell4,500$18.97$85,365.00149,058  
8/19/2020Christopher R LooseInsiderSell4,500$22.97$103,365.00152,782  
8/5/2020Christopher R LooseInsiderSell4,500$21.21$95,445.00157,340  
8/3/2020David L LucchinoCEOSell15,714$21.63$339,893.82386,658  
7/22/2020Christopher R LooseInsiderSell4,500$21.51$96,795.00161,782  
7/20/2020Joel S MarcusDirectorBuy55,555$18.00$999,990.00319,700  
7/8/2020Christopher R LooseInsiderSell4,500$22.32$100,440.00167,061  
7/1/2020David L LucchinoCEOSell15,714$22.45$352,779.30402,372  
6/24/2020Christopher R LooseInsiderSell4,500$22.80$102,600.00170,782  
6/10/2020Christopher R LooseInsiderSell4,500$19.96$89,820.00175,282  
6/1/2020David L LucchinoCEOSell11,875$17.91$212,681.25421,925  
5/21/2020Joel S MarcusDirectorSell5,000$18.81$94,050.00319,700  
5/20/2020Christopher R LooseInsiderSell4,500$19.02$85,590.00189,114  
5/8/2020David L LucchinoCEOSell10,478$18.18$190,490.04433,800  
5/6/2020Christopher R LooseInsiderSell4,500$16.28$73,260.00192,336  
5/5/2020David L LucchinoCEOSell5,239$16.19$84,819.41444,278  
5/1/2020David L LucchinoCEOSell5,236$15.28$80,006.08449,517  
4/23/2020David L LucchinoCEOSell1,410$16.08$22,672.80455,482  
4/22/2020Christopher R LooseInsiderSell4,500$14.84$66,780.00196,282  
4/17/2020David L LucchinoCEOSell3,100$16.00$49,600.00456,892  
4/15/2020David L LucchinoCEOSell5,236$15.13$79,220.68459,992  
4/8/2020Christopher R LooseInsiderSell4,500$14.99$67,455.00200,782  
10/7/2019James E FlynnInsiderBuy285,714$12.67$3,619,996.38
10/7/2019Marc A CohenDirectorBuy17,857$12.84$229,283.88
(Data available from 1/1/2013 forward)
This page was last updated on 10/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.